Mouse에서의 quercetin 경구투여 후의 체내 농도 및 대사체 isorhamnetin의 농도변화 = Tissue Concentrations of Quercetin and Its Metabolite Isorhamnetin Following Oral Administration of Quercetin in Mice

국문 초록 (Abstract)

Quercetin을 50 및 100mg/kg의 용량으로 mouse에 경구투여 후 흡수, 대사 및 조직내 농도를 조사하였으며 일부의 시험은 비교를 위해 rat에서도 수행하였다. Quercetin은 mouse에서 신속히 흡수되어 l시간 후면 최고 혈장내 농도에 도달하였으며 4시간 후에는 현저하게 농도가 감소하였다. 주요 대사체인 isorhamnetin의 혈장내 농도도 신속하게 증가하였으나 quercetin 보다는 높은 농도로 유지되는 시간이 길었다. Rat에서 알려진 현상과 같이 quercetin이나 isorhamnetin 모두 유리상태로 존재하지 않고 대부분 glucuronide/sulfate의 포합체 형태로 존재하였다. Quercetin 및 isorhamnetin의 조직내 농도는 투여 1시간 및 6시간 콩히 간장>신장>비장>혈장의 순이었으며 이 순서는 rat에서도 마찬가지였다. 이 연구결과를 통해 mouse에서 quercetin이 경구투여 후 실제로 흡수되며 사람이나 다른 동물종에서 관찰된 것과 같이 quercetin은 신속하게 전환됨을 관찰하였다. 또한 이 결과는 mouse를 이용한 실험에서 지금까지 규명된 quercetin의 다양한 약리효과를 설명하는 데 필요한 자료의 역할을 할 수 있을 것이다.

다국어 초록 (Multilingual Abstract)

Absorption, metabolism, and tissue concentrations of quercetin were examined and compared in mice and rats after oral administration of quercetin at 50 or 100 mg/kg. Quercetin was absorbed quickly in mice and reached maximum plasma concentration in I hr post-administration, and declined sharply after 4 hr. Plasma concentration of isorhamnetin, a major metabolite, also increased sharply, indicating rapid metabolic conversion, but elevated level was maintained longer than that of quercetin. Quercetin and isorhamnetin were found predominantly in glucuronide/sulfate-conjugate forms in both mice and rats. Tissue concentrations of quercetin and isorhamnetin in mice and rats were in the order of liver>kidney>spleen>plasma both 1 and 6 hr postadministration. These results show that quercetin is absorbed in mice after oral feeding and quickly metabolized into isorhamnetin as demonstrated in humans and other animal species. The results also can be used to explain various pharmacological activities reported in mouse models.

참고문헌 (Reference)

1 "Urinary and plasma levels of resveratrol and quercetin in humans and rats after injestion of pure compounds and grape juice" 935-942, 2004

2 "The sugar moeity is a major determinant of the absorption of dietary flavonoid glycosides in man" c (c): 569-573, 1999

3 "Studies on the protective effects of caffeic acid and quercetin on chemical-induced hepatotoxicity in rodents" 424-11 430, 2004

4 "Structure-antioxidant activity relationships of flavonoids and isoflavonoids Flavonoids in Health and Disease" Inc 1998

5 "Quercetin solubility affects its accumulation in rats after oral administration" 4313-4317, 1998

6 "Quercetin is recovered in human plasma as conjugated derivatives which retain antioxidant properties" 331-336, 1998

7 "Quercetin in foods Flavonoids in Health and Disease" Inc 1998

8 "Quercetin glucuronides but not glucosides are present in human plasma after consumption of quercetin-3-glucoside or quercetin-4'-glucoside" 2001

9 "Quercetin alleviates oxidative stress in streptozotocin-induced diabetic rats" 123-127, 2004

10 "Protective effects of quercetin on ultraviolet A light-induced oxidative stress in the blood of rat" 22 : 303-309, 2002

11 "Pharmacokinetics of quercetin from quercetin aglycone and rutin in healthy volunteers" 545-553, 2000

12 "Pharamcokinetic and bioavailability of the flavol quercetin in humans" 219-37 233, 1999

13 "Mechanism of actionof antiatherogenic and related effects of Ficus bengalensis Linn flavonoids in experimental animals" 296-303, 2003

14 "Induction of stress proteins by tobacco smoke in human monocytes modulation by antioxidants" pi (pi): 156-161, 1997

15 "High-performance liquid chromatographic determination of quercetin and isorhamnetin in rat tissues using b-glucuronidase and acid hydrolysis" 413-738 417, 2000

16 "Free radical scavenging abilities of flavonoids as mechanism of protection against mutagenicity induced by tert-butyhydroperoxide or cumene hydroperoxide in Salmonella typhimurium TA102 Mut Res" 9 : 1-18, 2003

17 "Flavone inhibition of tumor growth via apoptosis in vitro and in vivo" 661-670, 2004

18 "Disposition of the flavonoid quercetin in rats after single intravenous and oral doses" 29 : 397-403, 2003

19 "Deglycosylation of flavonoid glycosides by human small intestine and liver beta-glucosidase activity" 71-75, 1998

20 "Contents of potentially anticarcinogenic flavonoids in tea infusions" 1242-1246, 1993

21 "Comparison of the bioavailability of quercetin and catechin in rats" 1259-1266, 1999

22 "Comparative evaluation of cancer chemopreventive efficacy of alpha-tocopherol and quercetin in a murine model" 251-258, 2004

23 "Chemoprotective effects of plant phenolics against anthracycline-induced toxicity on rat cardiomyocytes" 516-521, 2004

24 "Bioavailability of the dietary antioxidant flavonol quercetin in man" 139-140, 1997

25 "Bioavailability and metabolism of the flavonol quercetin in the pig" 28 : 1056-1067, 2000

26 "Arrhythmogenic peroxynitrite-induced alterations in mammalian heart contractility and its prevention with quercetin-filled liposome" 129-139, 2002

27 "Antihypertensive effects of the flavonoid quercetin in spontaneously hypertensive rats" perez-vizcai (perez-vizcai): 117-124, 2001

28 "Antidiabetic effects of quercetin in streptozotocin-induced diabetic rats" c 135 : 357-364, 2003

29 "Analysis of the major flavonol glycosides present in four varieties of onion and changes in composition resulting from autolysis" 331-339, 1997

30 "Analysis of polyphenols in apple products" 48-51, 1997

31 "Advances in Research" Chapman and Hall the flavo (the flavo): 189-2591982

32 "Absorption of dietary quercetin glycosides and quercetin in healthy isolectomy volunteers" 1276-1282, 1995